Report Detail

Pharma & Healthcare Global and United States Montelukast API Market Report & Forecast 2022-2028

  • RnM4367119
  • |
  • 07 January, 2022
  • |
  • Global
  • |
  • 108 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Study Coverage

    • 1.1 Montelukast API Product Introduction
    • 1.2 Global Montelukast API Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Montelukast API Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global Montelukast API Sales in Volume for the Year 2017-2028
    • 1.3 United States Montelukast API Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States Montelukast API Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States Montelukast API Sales in Volume for the Year 2017-2028
    • 1.4 Montelukast API Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States Montelukast API in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of Montelukast API Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 Montelukast API Market Dynamics
      • 1.5.1 Montelukast API Industry Trends
      • 1.5.2 Montelukast API Market Drivers
      • 1.5.3 Montelukast API Market Challenges
      • 1.5.4 Montelukast API Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 Montelukast API Market Segment by Type
      • 2.1.1 Tablet
      • 2.1.2 Chewable Tablet
      • 2.1.3 Oral Solution
    • 2.2 Global Montelukast API Market Size by Type
      • 2.2.1 Global Montelukast API Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global Montelukast API Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global Montelukast API Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States Montelukast API Market Size by Type
      • 2.3.1 United States Montelukast API Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States Montelukast API Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States Montelukast API Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 Montelukast API Market Segment by Application
      • 3.1.1 Asthma
      • 3.1.2 Allergic Rhinitis
      • 3.1.3 Urticaria
      • 3.1.4 Bronchospasm
      • 3.1.5 Others
    • 3.2 Global Montelukast API Market Size by Application
      • 3.2.1 Global Montelukast API Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global Montelukast API Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global Montelukast API Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States Montelukast API Market Size by Application
      • 3.3.1 United States Montelukast API Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States Montelukast API Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States Montelukast API Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global Montelukast API Competitor Landscape by Company

    • 4.1 Global Montelukast API Market Size by Company
      • 4.1.1 Top Global Montelukast API Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global Montelukast API Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global Montelukast API Sales by Manufacturer (2017-2022)
      • 4.1.4 Global Montelukast API Price by Manufacturer (2017-2022)
    • 4.2 Global Montelukast API Concentration Ratio (CR)
      • 4.2.1 Montelukast API Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Montelukast API in 2021
      • 4.2.3 Global Montelukast API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Montelukast API Manufacturing Base Distribution, Product Type
      • 4.3.1 Global Montelukast API Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers Montelukast API Product Type
      • 4.3.3 Date of International Manufacturers Enter into Montelukast API Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Montelukast API Market Size by Company
      • 4.5.1 Top Montelukast API Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Montelukast API Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States Montelukast API Sales by Players (2020, 2021 & 2022)

    5 Global Montelukast API Market Size by Region

    • 5.1 Global Montelukast API Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Montelukast API Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global Montelukast API Sales in Volume by Region: 2017-2022
      • 5.2.2 Global Montelukast API Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global Montelukast API Market Size in Value by Region (2017-2028)
      • 5.3.1 Global Montelukast API Sales in Value by Region: 2017-2022
      • 5.3.2 Global Montelukast API Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Montelukast API Market Size YoY Growth 2017-2028
      • 6.1.2 North America Montelukast API Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Montelukast API Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Montelukast API Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Montelukast API Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Montelukast API Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Montelukast API Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Montelukast API Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Montelukast API Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Montelukast API Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Merck
      • 7.1.1 Merck Corporation Information
      • 7.1.2 Merck Description and Business Overview
      • 7.1.3 Merck Montelukast API Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 Merck Montelukast API Products Offered
      • 7.1.5 Merck Recent Development
    • 7.2 Cipla
      • 7.2.1 Cipla Corporation Information
      • 7.2.2 Cipla Description and Business Overview
      • 7.2.3 Cipla Montelukast API Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 Cipla Montelukast API Products Offered
      • 7.2.5 Cipla Recent Development
    • 7.3 Morepen Laboratories
      • 7.3.1 Morepen Laboratories Corporation Information
      • 7.3.2 Morepen Laboratories Description and Business Overview
      • 7.3.3 Morepen Laboratories Montelukast API Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 Morepen Laboratories Montelukast API Products Offered
      • 7.3.5 Morepen Laboratories Recent Development
    • 7.4 Sun Pharma
      • 7.4.1 Sun Pharma Corporation Information
      • 7.4.2 Sun Pharma Description and Business Overview
      • 7.4.3 Sun Pharma Montelukast API Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 Sun Pharma Montelukast API Products Offered
      • 7.4.5 Sun Pharma Recent Development
    • 7.5 Teva Pharmaceutical Industries
      • 7.5.1 Teva Pharmaceutical Industries Corporation Information
      • 7.5.2 Teva Pharmaceutical Industries Description and Business Overview
      • 7.5.3 Teva Pharmaceutical Industries Montelukast API Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 Teva Pharmaceutical Industries Montelukast API Products Offered
      • 7.5.5 Teva Pharmaceutical Industries Recent Development
    • 7.6 Intas Pharmaceuticals
      • 7.6.1 Intas Pharmaceuticals Corporation Information
      • 7.6.2 Intas Pharmaceuticals Description and Business Overview
      • 7.6.3 Intas Pharmaceuticals Montelukast API Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 Intas Pharmaceuticals Montelukast API Products Offered
      • 7.6.5 Intas Pharmaceuticals Recent Development
    • 7.7 Apotex
      • 7.7.1 Apotex Corporation Information
      • 7.7.2 Apotex Description and Business Overview
      • 7.7.3 Apotex Montelukast API Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 Apotex Montelukast API Products Offered
      • 7.7.5 Apotex Recent Development
    • 7.8 Sanyo Chemical Industries
      • 7.8.1 Sanyo Chemical Industries Corporation Information
      • 7.8.2 Sanyo Chemical Industries Description and Business Overview
      • 7.8.3 Sanyo Chemical Industries Montelukast API Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 Sanyo Chemical Industries Montelukast API Products Offered
      • 7.8.5 Sanyo Chemical Industries Recent Development
    • 7.9 Mylan
      • 7.9.1 Mylan Corporation Information
      • 7.9.2 Mylan Description and Business Overview
      • 7.9.3 Mylan Montelukast API Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 Mylan Montelukast API Products Offered
      • 7.9.5 Mylan Recent Development
    • 7.10 Delmar Chemicals
      • 7.10.1 Delmar Chemicals Corporation Information
      • 7.10.2 Delmar Chemicals Description and Business Overview
      • 7.10.3 Delmar Chemicals Montelukast API Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 Delmar Chemicals Montelukast API Products Offered
      • 7.10.5 Delmar Chemicals Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 Montelukast API Industry Chain Analysis
    • 8.2 Montelukast API Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 Montelukast API Distributors
    • 8.3 Montelukast API Production Mode & Process
    • 8.4 Montelukast API Sales and Marketing
      • 8.4.1 Montelukast API Sales Channels
      • 8.4.2 Montelukast API Distributors
    • 8.5 Montelukast API Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:
      Market Analysis and Insights: Global and United States Montelukast API Market
      This report focuses on global and United States Montelukast API market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Montelukast API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Tablet accounting for % of the Montelukast API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Asthma was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Montelukast API market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
      Global Montelukast API Scope and Market Size
      Montelukast API market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Montelukast API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Montelukast API market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Montelukast API market is segmented into
      Tablet
      Chewable Tablet
      Oral Solution
      Segment by Application, the Montelukast API market is segmented into
      Asthma
      Allergic Rhinitis
      Urticaria
      Bronchospasm
      Others
      Regional and Country-level Analysis
      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Montelukast API Market Share Analysis
      Montelukast API market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Montelukast API business, the date to enter into the Montelukast API market, Montelukast API product introduction, recent developments, etc.
      The major vendors covered:
      Merck
      Cipla
      Morepen Laboratories
      Sun Pharma
      Teva Pharmaceutical Industries
      Intas Pharmaceuticals
      Apotex
      Sanyo Chemical Industries
      Mylan
      Delmar Chemicals


      Summary:
      Get latest Market Research Reports on Montelukast API. Industry analysis & Market Report on Montelukast API is a syndicated market report, published as Global and United States Montelukast API Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Montelukast API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,350.00
      $8,700.00
      3,462.60
      6,925.20
      4,080.30
      8,160.60
      555,538.50
      1,111,077.00
      336,994.50
      673,989.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report